Projected Earnings Date: 2026-05-14    (Delayed quote data   2026-02-10)
Last
 299.83
Change
 ⇑ +5.00   (+1.70%)
Volume
  188,736
Open
 295.02
High
 301.47
Low
 294.58
8EMA (Daily)
 299.59
40EMA (Daily)
 305.96
50EMA (Daily)
 306.37
STO (Daily)
 41.089
MACD Hist (Daily)
 0.463
8EMA (Weekly)
 303.451
40EMA (Weekly)
 296.84
50EMA (Weekly)
 299.56
STO (Weekly)
 22.552
MACD Hist (Weekly)
 -3.583
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (60% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the United States (40% of 2020 sales), Europe (34%), and Asia (21%), with Canada and Latin America accounting for the bulk of the remaining 5%. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com